Clinical implications of research on the box-jellyfish Chironex fleckeri
- 1 November 1994
- Vol. 32 (11) , 1305-1313
- https://doi.org/10.1016/0041-0101(94)90403-0
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Pressure-immobilization first aid for snakebite—fact and fancyToxicon, 1993
- Verapamil potentiation of Chironex (box-jellyfish) antivenomToxicon, 1990
- Recurrent eruptions following unusual solitary coelenterate envenomationsJournal of the American Academy of Dermatology, 1987
- Pharmacological effects of various venoms on cutaneous capillary leakageToxicon, 1986
- Sea‐wasp antivenom in a toddlerThe Medical Journal of Australia, 1984
- Box‐jellyfish cardiotoxin and i.v. verapamil: In replyThe Medical Journal of Australia, 1984
- Response of the box‐jellyfish (Chfronex fleckeri) cardiotoxin to intravenous administration of verapamilThe Medical Journal of Australia, 1983
- The chemistry and toxicology of some venomous pelagic coelenteratesToxicon, 1977
- Sea wasp (Chironex fleckeri) antivenene: Neutralizing potency against the venom of three other jellyfish speciesToxicon, 1974
- Sea wasp (Chironex fleckeri) venom: Lethal, haemolytic and dermonecrotic propertiesToxicon, 1969